SCHEMBL19844142

SCHEMBL19844142

c1ccc(-n2c3ccccc3c3cc(-n4c5cc6ccccc6cc5c5c6ccccc6c6ccccc6c54)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36
KDR P35968 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
PTPN1 P18031 2/20 0.33
ALDH1A1 P00352 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
BRCA1 P38398 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
F2 P00734 1/20 0.31
F10 P00742 1/20 0.31
PRSS1 P07477 1/20 0.31
PPARG P37231 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18668067 0.94 KDM4E (0.47) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL18667990 0.92 KDM4E (0.36) KDM4EATML3MBTL1SIGMAR1ALDH1A1
SCHEMBL18668061 0.92 KDM4E (0.46) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL18667993 0.91 KDM4E (0.43) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL23917170 0.90 KDM4E (0.39) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL18667989 0.89 KDM4E (0.43) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL17990345 0.89 L3MBTL1 (0.51) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL19131235 0.88 L3MBTL1 (0.40) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL17071299 0.88 KDM4E (0.39) KDM4EATML3MBTL1JAK2JAK3
SCHEMBL18667702 0.88 L3MBTL1 (0.41) KDM4EATML3MBTL1JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same LG CHEM, LTD. (KR) 2019-09-24 US disclosed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US disclosed
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421721-B2 Heterocyclic compound and organic light emitting device comprising same CRY1, CRY2, PER2 KDM4E 2554/4885ATM 3310/4885L3MBTL1 856/4885
US-20180037547-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 KDM4E 2554/4885ATM 3310/4885L3MBTL1 856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.